Clinical Trials in North Carolina

Showing 6641-6660 of 15,496 trials

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

NCT05108935

The purpose of this study is to provide medication for opioid use disorder (MOUD) with buprenorphine and naloxone, or bup/nx, pre-exposure prophylaxis (PrEP) for HIV prevention, and/or hepatitis C treatment for persons who inject opioids accessing syringe services programs (SSPs), as part of a comprehensive harm reduction program, and assess the acceptability and feasibility of using telemedicine to implement the program. The initial visit will be conducted in person or remotely via telemedicine given COVID-19 protocols at the SSP site in Greensboro, North Carolina (NC); follow-up visits will be conducted via telemedicine.

Opioid UseOpioid Use DisorderRisk Reduction+2 more

Duke University17 participantsStarted Feb 2022

Durham, North Carolina, United States • Greensboro, North Carolina, United States

COMPLETEDPhase 331 miles

Randomized Trial in Adult Participants With Acute Migraines

NCT04571060

The purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.

Migraine

Pfizer1,978 participantsStarted Oct 2020

Huntsville, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +91 more locations

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Randomized Trial in Adult Participants With Acute Migraines

Find Trials by Condition in North Carolina

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

FX-322 in Adults With Stable Sensorineural Hearing Loss

HIRREM for Stage 1 Primary Hypertension

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)

Relative Bioavailability of LY03010 Compared to Listed Drug

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Rapid Diagnostics for HIV and Hepatitis

Video Gaming for Home Rehabilitation for Children With Hemiplegic Cerebral Palsy in Costa Rica

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations